28 June 2024
Strengthening Measures Against Antibiotic Resistance
The Federal Council has approved the One Health Action Plan “Swiss Strategy on Antibiotic Resistance” (StAR) 2024–2027 to combat rising antibiotic resistance. This plan ensures the long-term effectiveness of antibiotics for humans and animals by focusing on early detection of resistance, monitoring antibiotic use, reducing environmental contamination, and developing new antibiotics. Implemented by federal offices in health, veterinary, agriculture, and environment sectors, the plan involves collaboration with cantons and stakeholders, with updated legislation supporting ongoing efforts.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: Haemovigilance Annual Report 2025
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting